Skip to main content
Syngene International Limited (NSE:SYNGENE)
India flag India · Delayed Price · Currency is INR
653.40
-95.75 (-12.78%)
Apr 24, 2025, 3:30 PM IST

Syngene International Revenue

In the fiscal year ending March 31, 2025, Syngene International had annual revenue of 37.14B INR with 6.47% growth. Syngene International had revenue of 10.37B in the quarter ending March 31, 2025, with 13.09% growth.

Revenue
37.14B
Revenue Growth
+6.47%
P/S Ratio
8.09
Revenue / Employee
5.71M
Employees
6,510
Market Cap
300.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202537.14B2.26B6.47%
Mar 31, 202434.89B2.96B9.26%
Mar 31, 202331.93B5.89B22.61%
Mar 31, 202226.04B4.20B19.22%
Mar 31, 202121.84B1.72B8.57%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 516.03B
Divi's Laboratories 90.78B
Cipla 267.20B
Mankind Pharma 116.41B
Apollo Hospitals Enterprise 211.46B
Zydus Lifesciences 222.47B
Aurobindo Pharma 309.22B
Alkem Laboratories 127.57B
Revenue Rankings

Syngene International News

More News